World demand to rise 6.4% annually through 2017
World pharmaceutical packaging demand will increase 6.4 percent annually to $90 billion in 2017. Based on the operation of extensive and diverse drug-producing industries, Western Europe, the US, and Japan will account for nearly 60 percent of this amount. Among all countries, India and China will record the fastest growth in product demand due to rapidly expanding pharmaceutical manufacturing capabilities, burgeoning drug exports, and the phasing-in of an extensive govern ment program designed to upgrade the quality and integrity of nationally produced medicines. Brazil, Mexico, and Turkey will also evolve into fast-growing pharmaceutical packaging product markets as drug-producing sectors are upgraded and diversified, especially in the area of generic ethical drugs.
US to remain largest market
Among individual countries, the US will remain the largest market for pharmaceutical packaging products as its advanced drug-producing sector introduces new sophisticated therapies with specialized packaging needs. Growth in West European demand will reflect upgraded government standards requiring unit dose, high barrier, and security packaging for many types of medication. Based on its broad range of proprietary and generic drug producers, Japan will continue to comprise a large, diverse market for pharmaceutical containers, closures and related accessories. However, the country will provide below average growth opportunities as drug makers pursue greater packaging efficiencies to offset downward pressures on medication prices.
Prefillable syringes to pace primary drug containers
Global demand for primary pharmaceutical containers will increase 6.6 percent annually to over $57 billion in 2017. The fastest growth is anticipated for prefillable syringes, which will gain applications as advances in biotechnology lead to the introduction of new parenteral therapies. The same trend will also create above average growth in world demand for parenteral vials and ampuls. In spite of increasing competition from alternative containers, plastic bottles will remain the most widely used package globally for oral drugs distributed in bulk and prescription dose volumes to retail and mail order pharmacies. Plastic bottles will also continue to dominate applications as containers for OTC medicines sold in tablet and capsule quantities of 50 or more. Blister packaging will comprise the second-largest selling group of primary pharmaceutical containers and will generate above average growth in demand based on adaptability to unit dose and clinical trial formats with expanded label content, high visibility, and built-in track and trace features.
Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=250062.
Prefillable inhalers will realize above average growth in global demand as the number of chronic asthma, allergy, and migraine patients treated with inhalation drugs rises. By contrast, worldwide consumption of pharmaceutical pouches and medication tubes will expand at a subpar pace as the vast majority of applications remain limited to topical medication packaging. Uses in the packaging of premixed drugs and parenteral nutritional preparations will keep global demand for IV containers increasing at a near average pace through 2017. Conversely, world consumption of glass pharmaceutical bottles will decrease gradually over the long term as plastic bottles and blister packs continue to capture market share. Strip packs and paperboard boxes will be the largest segments among other primary pharmaceutical containers based on adaptability to economical unit dose formats.
Company Profiles
Profiles global players such as Amcor, Becton Dickinson, Gerresheimer, MeadWestvaco, Rexam, SCHOTT, and West Pharmaceutical Services
Get a complete copy @ http://www.reportsnreports.com/reports/250062-world-pharmaceutical-packaging-to-2017.html.
Contact [email protected] for more details.
